Advisory Committee for Therapeutics (TACT)

The success of the TREAT-NMD Advisory Committee for Therapeutics (TACT) is built on the dedication and expertise of its core committee. This group of global experts forms the backbone of TACT, attending every meeting and contributing their time, insight, and experience to support therapy development in rare neuromuscular diseases. In addition to the core, each TACT review is complete by an extended committee, which creates a bespoke panel for each applicant. Their multidisciplinary perspectives, from clinical care and research to industry and patient advocacy, ensures that each review is thorough, balanced, and impactful. TACT simply wouldn’t be what it is today without their tireless efforts and commitment to advancing meaningful treatments.